PeptideScanner retained ClinicalTrials.gov record NCT02974907 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-10-21, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1